Drug Profile
Iron sucrose - CSL Vifor
Alternative Names: VenoferLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Vifor Pharma
- Developer American Regent; CSL Vifor
- Class Antianaemics; Carbohydrates; Ferric compounds; Small molecules
- Mechanism of Action Iron replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Iron deficiency anaemia